Search

Your search keyword '"Michal, Tendera"' showing total 320 results

Search Constraints

Start Over You searched for: Author "Michal, Tendera" Remove constraint Author: "Michal, Tendera"
320 results on '"Michal, Tendera"'

Search Results

1. Transcoronary stem cell transfer and evolution of infarct-related artery atherosclerosis: evaluation with conventional and novel imaging techniques including Quantitative Virtual Histology (qVH)

2. Cardiopoietic stem cell therapy in ischaemic heart failure: long‐term clinical outcomes

3. ESC EORP Cardiomyopathy Registry: real‐life practice of genetic counselling and testing in adult cardiomyopathy patients

4. Optimal or standard control of systolic and diastolic blood pressure across risk factor categories in patients with chronic coronary syndromes

5. EXPERT CONSENSUS DOCUMENT ON ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CARDIOVASCULAR DISEASE

6. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk

7. International Observational Analysis of Evolution and Outcomes of Chronic Stable Angina: The Multinational CLARIFY Study

8. Prevalence, Incidence and Prognostic Implications of Left Bundle Branch Block in Patients with Chronic Coronary Syndromes (From the CLARIFY Registry)

9. ESC GUIDELINES ON DIABETES, PRE-DIABETES, AND CARDIOVASCULAR DISEASES DEVELOPED IN COLLABORATION WITH THE EASD

10. Use of risk scores to identify lower and higher risk subsets among <scp>COMPASS‐eligible</scp> patients with chronic coronary syndromes. Insights from the <scp>CLARIFY</scp> registry

11. Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry.

12. 55th EASD Annual Meeting of the European Association for the Study of Diabetes

13. β-blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort study

14. Impact of chronic kidney disease on use of evidence-based therapy in stable coronary artery disease: a prospective analysis of 22,272 patients.

15. Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarction

16. Prevalence of diabetic and impact on cardiovascular events and mortality in patients with chronic coronary syndromes, across multiple geographical regions and ethnicities

17. Correlation between electromechanical parameters (NOGA XP) and changes of myocardial ischemia in patients with refractory angina

18. Cardiovascular risk of chronic coronary syndrome patients according to vascular phenotype, diabetes and smoking

19. Cardiopoietic stem cell therapy in ischaemic heart failure: long-term clinical outcomes

20. Artificial Intelligence Can Improve Patient Management at the Time of a Pandemic: The Role of Voice Technology (Preprint)

21. Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial

22. Prospective follow-up in various subtypes of cardiomyopathies: insights from the ESC EORP Cardiomyopathy Registry

23. P961 Diagnostic use of proportion between ascending aorta and left atrium in patients referred for coronary artery calcium scoring

24. Atrial fibrillation, anticoagulation management and risk of stroke in the Cardiomyopathy/Myocarditis registry of the EURObservational Research Programme of the European Society of Cardiology

25. Relationship between physical activity and long-term outcomes in patients with stable coronary artery disease

26. Recomendações da ESC para o tratamento da cardiopatia congénita no adulto (nova versão de 2010)

27. Heart rate and use of beta-blockers in stable outpatients with coronary artery disease.

28. Chronic Kidney Disease Has a Graded Association with Death and Cardiovascular Outcomes in Stable Coronary Artery Disease: An Analysis of 21,911 Patients from the CLARIFY Registry

29. Impact of smoking on cardiovascular outcomes in patients with stable coronary artery disease

30. Incident heart failure in outpatients with chronic coronary syndrome: results from the international prospective CLARIFY registry

31. Potential impact of the 2017 ACC/AHA guideline on high blood pressure in normotensive patients with stable coronary artery disease: insights from the CLARIFY registry

32. Simple risk models to predict cardiovascular death in patients with stable coronary artery disease

33. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)

34. Artificial Intelligence Can Improve Patient Management at the Time of a Pandemic: The Role of Voice Technology

35. The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction: rationale and design of the BAMI trial

36. Rationale, design, and baseline characteristics of the CLARIFY registry of outpatients with stable coronary artery disease

37. Effects of Transendocardial Delivery of Bone Marrow–Derived CD133 + Cells on Left Ventricle Perfusion and Function in Patients With Refractory Angina

38. Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention

39. Prevalence, incidence and prognostic implications of left bundle branch block in patients with stable coronary artery disease. An analysis from the CLARIFY registry

40. Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registry

41. 1479-P: Predictors of Incident Hospitalization for Heart Failure in the ACE Trial Population

42. Management strategies and 5-year outcomes in Polish patients with stable coronary artery disease in the CLARIFY registry versus other European countries

43. Living alone and cardiovascular disease outcomes

44. Generalizability of the REDUCE-IT Trial in Patients With Stable Coronary Artery Disease

45. Vorapaxar in patients with coronary artery bypass grafting: Findings from the TRA 2°P-TIMI 50 trial

46. A single-centre, randomised study on platelet reactivity after abrupt or gradual discontinuation of long-term clopidogrel therapy in patients after percutaneous coronary intervention

47. Transcatheter paravalvular leak closure and hemolysis – a prospective registry

48. Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART‐1) trial design

49. Use of risk score to identify lower and higher risk subsets among COMPASS-Eligible patients with stable CAD. Insights from the CLARIFY Registry

50. Frequency, management and outcomes of patients with stable coronary artery disease eligible for COMPASS. An analysis of the CLARIFY Registry

Catalog

Books, media, physical & digital resources